107967-05-5

Basic information

• Product Name: [1-(4-Methoxyphenyl)-2-(2-nitrophenyl)ethyl]-propanedioic acid,dimethyl ester
• Synonyms: [1-(4-Methoxyphenyl)-2-(2-nitrophenyl)ethyl]-propanedioic acid,dimethyl ester
• CAS NO: 107967-05-5
• Molecular Weight: 387.389
• Mol File: 107967-05-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: [1-(4-Methoxyphenyl)-2-(2-nitrophenyl)ethyl]-propanedioic acid,dimethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(4-Methoxyphenyl)-2-(2-nitrophenyl)ethyl]-propanedioic acid,dimethyl ester(107967-05-5)
• EPA Substance Registry System: [1-(4-Methoxyphenyl)-2-(2-nitrophenyl)ethyl]-propanedioic acid,dimethyl ester(107967-05-5)

Safety Data

• Hazardous Substances Data: 107967-05-5(Hazardous Substances Data)

Upstream product

• 88-72-2 1-methyl-2-nitrobenzene 
• 7443-25-6 dimethyl 2-(4-methoxybenzylidene)malonate 

Downstream Products

• 138573-23-6 2-[1-(4-Methoxy-phenyl)-2-(2-nitro-phenyl)-ethyl]-2-propyl-malonic acid dimethyl ester 
• 119217-59-3 α-(2-Propenyl)-[2-(2-nitrophenyl)-1-(4-methoxyphenyl)ethyl]propanedioic acid, dimethyl ester 
• 107967-06-6 <2-(2-aminophenyl)-1-(4-methoxyphenyl)ethyl>propanedioic acid, dimethyl ester 
• 119217-58-2 trans-1,3,4,5-tetrahydro-3-methyl-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one 
• 129151-94-6 cis-3-(acetyloxy)-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one, monohydrochloride 
• 129151-93-5 cis-3-hydroxy-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one, monohydrochloride 
• 119217-36-6 cis-3-methyl-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one, monohydrochloride 
• 138335-44-1 (3R,4S)-1-(2-Dimethylamino-ethyl)-4-(4-methoxy-phenyl)-3-propyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 119217-37-7 (3R,4S)-1-(2-Dimethylamino-ethyl)-4-(4-methoxy-phenyl)-3-methyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 119217-62-8 (3R,4S)-3-Allyl-4-(4-methoxy-phenyl)-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 138573-49-6 (3S,4R)-4-(4-Methoxy-phenyl)-2-oxo-3-propyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 119217-61-7 (3S,4R)-3-Allyl-4-(4-methoxy-phenyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 119217-57-1 (3S,4R)-4-(4-Methoxy-phenyl)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 138573-61-2 4-(4-Methoxy-phenyl)-3-propyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 

Relevant articles and documents

Fluoride-catalyzed Michael addition of nitrotoluenes to activated α, β-unsaturated esters

We have found that in the presence of fluoride ion, nitrotoluenes of type 1 undergo Michael addition to activated α, β-unsaturated esters of type 2 in good to excellent yield (Scheme 1). The generality and limitation of this reaction and its application t

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

We have synthesized a series of benzazepinones (2) in order to determine the structure-activity relationships (SAR) for calcium channel blockers related to diltiazem. A prerequisite for calcium channel blocking activity in vitro and in vivo is the presenc

Benzazepine derivatives

Vasodilating activity is exhibited by compounds having the formula STR1 and pharmaceutically acceptable salts thereof.